FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | ||
|
|||
Member
|
|
||
![]() |
![]() |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
Dyskinesias Study Results from Phase 1/2 NP002 in the Treatment of | Parkinson's Disease Clinical Trials | |||
Knopp Neurosciences Presents Results of Phase 1 Ascending Single-Dose Study of KNS-76 | ALS News & Research | |||
Ceregene announces positive phase 1 results ... | Parkinson's Disease | |||
Positive Results of Phase 3 Study of Fampridine-SR on walking | Multiple Sclerosis |